Luca Grisetti

Mr. Grisetti earned his bachelor’s degree in 2017 in Natural Sciences at Università Degli Studi di Milano, Italy. Since he developed a strong interest in human genetics and genomics, he attended the Master’s degree in Functional Genomics at Università Degli Studi di Trieste, Italy, graduating in 2020. This Master offered him a deep comprehension of the omics world, with cancer biology and transcriptomics as his major preferences. Therefore, he was enthusiastic to join a Master's thesis project based on the identification of serum miRNAs as possible diagnostic and predictive biomarkers of Hepatocellular carcinoma (HCC), thus being involved in translational research. To progress in the study of liver changes during hepatocarcinogenesis correlated to translational research, he started his Ph.D. in the Molecular Biomedicine program at the University of Trieste working at Fondazione Italiana Fegato (Italian Liver foundation) – ONLUS in Trieste, Italy. He is now a second-year Ph.D. student,

EDUCATION

09/2014 – 07/2017 Milano, Italy
Bachelor's degree in Natural Science, Università degli Studi di Milano, Milano, Italy

11/2020 – CURRENT Trieste, Italy
PH.D. student in molecular biomedicine, Università degli Studi di Trieste, Trieste, Italy

10/2017 – 07/2020 Trieste, Italy
Master's degree in Functional Genomics, Università degli Studi di Trieste, Trieste, Italy

RESEARCH INTERESTS

Cancer; Oncology; Liver; HCC; Molecular biology; Immune system

Publications

MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma
Luca Grisetti, Niem Văn Thành Võ, Nhu Nhat Quynh Nguyen, Lory Saveria Crocè, Alessia Visintin, Claudio Tiribelli, Devis Pascut
DOI: 10.1177/15330338221132924

Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
Loraine Kay D. Cabral †, Luca Grisetti †, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut
† These authors contributed equally to this work.
DOI: 10.3390/cancers14112700